A role for casein kinase II phosphorylation in the regulation of IRF-1 transcriptional activity

Molecular and Cellular Biochemistry

Volumn 191, Issue 1-2, 1999, Pages 169-180

  Lin, Rongtuan ^a,b   Hiscott, John ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Casein kinase II; Interferon; NF kappa B; Phosphorylation; Transcription

Indexed keywords

AMINO ACID; CASEIN KINASE II; CELL EXTRACT; INTERFERON; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2; PHOSPHOTRANSFERASE; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR;

AFFINITY CHROMATOGRAPHY; ARTICLE; BACULOVIRUS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ESCHERICHIA COLI; GENE DELETION; GROWTH REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOREGULATION; LEUKEMIA CELL LINE; MOLECULAR WEIGHT; POINT MUTATION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; T LYMPHOCYTE; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIRUS INFECTION;

ESCHERICHIA COLI; INSECTA; UNIDENTIFIED BACULOVIRUS;

EID: 0033000436     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1006850009017     Document Type: Article

References (64)

1. Hiscott J, Nguyen H, Lin R: Molecular mechanisms of interferon beta gene induction. SeminVirol 6: 161-173, 1995
2. Fujita T, Sakakibara J, Sudo Y, Miyamoto M, Kimura Y, Taniguchi T: Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-β gene regulatory elements. EMBO J 7: 3397-3405, 1988
3. Miyamoto M, Fujita T, Kimura Y, Maruyama M, Harada H, Sudo Y, Miyata T, Taniguchi T: Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to the IFN-β gene regulatory elements. Cell 54: 903-913, 1988
4. Fujita T, Kimura Y, Miyamoto M, Barsoumian EL, Taniguchi T: Induction of endogenous IFN-α and IFN-β genes by a regulatory transcription factor IRF-1. Nature 337: 270-272, 1989
5. Harada H, Fujita T, Miyamoto M, Kimura Y, Maruyama M, Furia A, Miyata T, Taniguchi T: Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58: 729-739, 1989
6. Nguyen H, Hiscott J, Pitha PM: The growing family of IRF transcription factors. Cyt Growth Fact Rev 8: 293-312, 1997
7. Reis LFL, Harada H, Wolchok JD, Taniguchi T, Vilcek J: Critical role of a common transcription factor, IRF-1, in the regulation of IFN-β and IFN-inducible genes. EMBO J 11: 185-193, 1992
8. Uegaki K, Shirakawa M, Fujita T, Taniguchi T, Kyogoku Y: Characterization of the DNA binding domain of the mouse IRF-2 protein. Protein Eng 6: 195-200, 1993
9. Lin R, Mustafa A, Nguyen H, Hiscott J: Mutational analysis of interferon (IFN) regulatory factors 1 and 2: Effects on the induction of IFN-β gene expression. J Biol Chem 269: 17542-17549, 1994
10. Yamamoto H, Lamphier MS, Fujita T, Taniguchi T, Harada H: The oncogenic transcription factor IRF-2 possesses a transcriptional repression and a latent activation domain. Oncogene 9: 1423-1428, 1994
11. Harada H, Kitagawa M, Tanaka N, Yamamoto H, Harada K, Ishihara M, Taniguchi T: Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 259: 971-974, 1993
12. Willman CL, Sever CE, Pallavicini MG, Harada H, Tanaka N, Slovak ML, Yamamoto H, Harada K, Meeker TC, List AF, Taniguchi T: Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasias. Science 259: 968-971, 1993
13. Harada H, Kondo T, Ogawa S, Tamura T, Kitagawa M, Tanaka N, Lamphier MS, Hisamaru H, Taniguchi T: Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; a possible mechanism of tumor suppressor inactivation. Oncogene 9:3313-3320, 1994
14. Kondo T, Minamino N, Nagamura-Inoue T, Matsumoto M, Taniguchi T, Tanaka N: Identification and characterization of nucleophosmin/ B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity. Oncogene 15: 1275-1281, 1997
15. Kirchoff S, Koromilas AE, Schaper F, Grashoff M, Sonenberg N, Hauser H: IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR. Oncogene 11: 439-445, 1995
16. Yang Y-L, Reis LFL, Pavlovic J, Aguzzi A, Schaefer R, Kumar A, Williams BRG, Aguet M, Weissman C: Deficient signalling in mice devoid of double-stranded RNAdependent protein kinase. EMBO J 14: 6095-6106, 1995
17. Kumar A, Yang Y-L, Flati V, Der S, Kadereit S, Deb A, Haque J, Reis L, Weissman C, Williams BRG: Deficient cytokine signalling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: Role of IRF-1 and NF-κB. EMBO J 16: 406-416, 1997
18. Tamura T, Ishihara M, Lamphier MS, Tanaka N, Oishi I, Aizawa S, Matsuyama T, Mak TW, Taki S, Taniguchi T: An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T-lymphocytes. Nature 376: 596-599, 1995
19. Ozawa H, Matsuyama T, Mak TW, Aizawa S, Tokino T, Oren M, Taniguchi T: Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature 382: 816-818, 1996
20. Nguyen H, Lin R, Hiscott J: Activation of multiple growth regulatory genes following inducible expression of IRF-1 or IRF/RelA fusion proteins. Oncogene 15: 1425-1435, 1997
21. Tan RS, Taniguchi T, Harada H: Identification of the lysyl oxidase gene as target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression. Cancer Res 56: 2417-2421, 1996
22. Matsuyama T, Kimura T, Kitagawa M, Watanabe N, Kundig T, Amakawa R, Kishihara K, Wakeham A, Potter J, Furlonger C, Narendran A, Suzuki H, Ohashi P, Paige C, Taniguchi T, Mak T: Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN induction and aberrant lymphocyte development. Cell 75: 83-97, 1993
23. Taki S, Sato T, Ogasawara K, Fukuda T, Sato M, Hida S, Suzuki G, Mitsuyama M, Furuta T, Kojima S, Taniguchi T, Asano Y: Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 6: 1-20, 1997
24. Duncan GS, Mittrucker HW, Kagi D, Matsuyama T, Mak TW: The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo. J Exp Med 184: 2043-2048, 1996
25. Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, Shapiro D, Le J, Koh SI, Kimura T, Green SJ, Mak TW, Taniguchi T, Vilcek J: Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263: 1612-1615, 1994
26. Martin E, Nathan C, Xie Q: Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med 180: 977-984, 1994
27. Pinna LA: Casein kinase II: An 'Eminence grise' in cellular regulation? Biochim Biophys Acta 1054: 267-284, 1990
28. Lin R, Gewert D, Hiscott J: Differential transcriptional activation in vitro by NF-κB/Rel proteins. J Biol Chem 270: 3123-3131, 1995
29. Lin R, Beauparlant P, Makris C, Meloche S, Hiscott J: Phosphorylation of IκBα in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability. Mol Cell Biol 16: 1401-1409, 1996
30. Hibi M, Lin A, Minden M, Karin M: Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 7: 2135-2148, 1993
31. Garoufalis E, Kwan I, Lin R, Mustafa A, Pepin N, Roulston A, Lacoste J, Hiscott J: Viral induction of the human interferon beta promoter: Modulation of transcription by NF-κB/rel proteins and interferon regulatory factors. J Virol 68: 4707-4715, 1994
32. Thanos D, Maniatis T: Identification of the rel family members required for virus induction of the human beta interferon gene. Mol Cell Biol 15: 152-164, 1995
33. Leblanc J-F, Cohen L, Rodrigues M, Hiscott J: Synergism between distinct enhanson domains in viral induction of the human beta interferon gene. Mol Cell Biol 10: 3987-3993, 1990
34. Meisner H, Czech MP: Phosphorylation of transcriptional factors and cell-cycle-dependent proteins by casein kinase Il. Curr Opin Cell Biol 3: 474-483, 1991
35. Krek W, Maridor G, Nigg EA: Casein kinase II is a predominantly nuclear enzyme. J Cell Biol 116: 43-55, 1992
36. Yu IJ, Spector DL, Bac Y-S, Marshak DR: Immunocytochemical localization of casein kinase II during interphase and mitosis. J Cell Biol 114: 1217-1232, 1991
37. Lin A, Frost J, Deng T, Smeal T, al-Alawi N, Kikkawa U, Hunter T, Brenner D, Karin M: Casein kinase II is a negative regulator of c-Jun DNAbinding and AP-1 activity. Cell 70: 777-789, 1992
38. McElhinny JA, Trushin SA, Bren GD, Chester N, Paya CV: Casein kinase II phosphorylates IκBα at S-283, S-289,S-293, and T-291 and is required for its degradation. Mol Cell Biol 16: 899-906, 1996
39. Barroga CF, Stevenson JK, Schwarz EM, Verma IM: Constitutive phosphorylation of IκBα by casein kinase II. Proc Natl Acad Sci USA 92: 7637-7641, 1995
40. Roulston A, Lin R, Beauparlant P, Wainberg MA, Hiscott J: Regulation of HIV-1 and cytokine gene expression in myeloid cells by NF-κB/ Rel transcription factors. Microbiol Rev 59: 481-505, 1995
41. Thanos D, Maniatis T: NF-κB: A lesson in family values. Cell 80: 529-532, 1995
42. Verma IM, Stevenson JK, Schwarz EM, Antwerp DV, Miyamoto S: Rel/NFκB/IκB family: Intimate tales of association and dissociation. Genes Dev 9: 2723-2735, 1995
43. Baeuerle PA, Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 12: 141-179, 1994
44. Baldwin AS Jr: The NF-κB and IκB proteins: New discoveries and insights. Annu Rev Immunol 14: 649-681, 1996
45. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U: Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science 267: 1485-1488, 1995
46. Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY, Ballard DW: Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol Cell Biol 15: 2809-2818, 1995
47. Traenckner EBM, Pahl HL, Henkel T, Schmidt KN, Wilk S, Baeuerle PA: Phosphorylation of human IκBα on serines 32 and 36 controls IκBα proteolysis and NF-κB activation in response to diverse stimuli. EMBO J 14: 2876-2883, 1995
48. Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, Maniatis T: Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev 9: 1586-1597, 1995
49. Scherer DC, Brockman JA, Chen Z, Maniatis T, Ballard DW: Signal-induced degradation of IκBα requires site-specific ubiquitination. Proc Natl Acad Sci USA 92: 11259-11263, 1995
50. Rodriguez MS, Wright J, Thompson J, Thomas D, Baleux F, Virelizier JL, Hay RT, Arenzana-Seisdedos F: Identification of lysine residues for signal-induced ubiquitination and degradation of IκBα in vivo. Oncogene 12: 2425-2435, 1996
51. Régnier C, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M: Identification and characterization of an IκB kinase. Cell 90: 373-383, 1997
52. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M: A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388: 548-554, 1997
53. Rodriguez MS, Michalopoulos I, Arenzana-Seisdedos F, Hay RT: Inducible degradation of IκBα in vitro and in vivo requires the acidic C-terminal domain of the protein. Mol Cell Biol 15: 2413-2419, 1995
54. Beauparlant P, Lin R, Hiscott J: The role of the C-terminal domain of IκBα in protein degradation and stability. J Biol Chem 271: 10690-10696, 1996
55. Ernst MK, Dunn LL, Rice NR: The PEST-like sequence of IκBα is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers. Mol Cell Biol 15: 872-882, 1995
56. Jaffray E, Wood KM, Hay RT: Domain organization of IκBα and the sites of interaction with NF-κB p65. Mol Cell Biol 15: 2166-2172, 1995
57. Brown K, Franzoso G, Baldi L, Carlson L, Mills L, Lin Y-C, Gerstberger S, Siebenlist U: The signal response of IκBα is regulated by transferable N- and C- terminal domains. Mol Cell Biol 17: 3021-3027, 1997
58. Beauparlant P, Kwon H, Clarke M, Lin R, Sonenberg N, Wainberg M, Hiscott J: Transdominant mutants of IκBα block Tat-TNF synergistic activation of HIV-1 expression and virus multiplication. J Virol 70: 5777-5785, 1996
59. Wu B-Y, Woffendin C, Duckett CS, Ohno T, Nabel GJ: Regulation of human retroviral latency by the NF-κB/IκB family: Inhibition of human immunodeficiency virus replication by licb through a Rev-dependent mechanism. Proc Natl Acad Sci USA 92: 1480-1484, 1995
60. Fritz CC, Zapp ML, Green MR: A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature 376: 530-533, 1995
61. Bogerd H, Flidell RA, Madore S, Cullen BR: Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins. Cell 82: 485-494, 1995
62. Stutz F, Neville M, Rosbash M: Identification of a novel pore-associated protein as a functional target of the HIV-1 Rev protein in yeast. Cell 82: 495-506, 1995
63. Fritz CC, Green MR: HIV Rev uses a conserved cellular protein export pathway for the nucleocytoplasmic transport of viral RNAS. Curr Biol 6: 848-854, 1996
64. Arenzana-Seisdedos F, Thompson J, Rodriguez MS, Bachelerie F, Thomas D, Hay RT: Inducible nuclear expression of newly synthesized IκBα negatively regulates DNA-binding and the transcriptional activities of NF-κB. Mol Cell Biol 15: 2689-2696, 1995